Rebecca Horwitz, partner at Bartlit Beck LLP, is well known for her extensive experience as lead counsel in a range of complex patent infringement litigations and Hatch-Waxman cases. Horwitz has expertise representing clients in the life sciences space, including medical devices, diagnostics and pharma companies, typically involving key national and international market players.
Legal 500 Editorial commentary
Accolades
Chicago Elite
Profile
Education
The University of Chicago Law School, 2013, J.D.
Wellesley College, 2006, B.A., Classics, Pre-medical Studies
Content supplied by Bartlit Beck LLP
Key clients
- Gilead
- Northwestern University
- Zentian, Ltd.
Work highlights
Represented Gilead Sciences as lead counsel in a Hatch-Waxman patent infringement litigation against three generic drug manufacturers regarding Gilead's novel HIV drug bictegravir.
Representing Northwestern University in a patent infringement lawsuit against Moderna in the District of Delaware, alleging that Moderna used Northwestern's patented lipid nanoparticle (LNP) technology in its vaccines, including the COVID-19 vaccine.
Represented Northwestern University in a series of patent infringement lawsuits related to collaborative robots, suing six cobot manufacturers- Universal Robots, ABB, KUKA, FANUC, Yaskawa, and Mitsubishi. Five of the six cases settled before trial.